Phase II Clinical Trial of LEVI-04

Levicept is conducting a multiple arm, multicentre, prospective, randomized, double-blind, placebo-controlled, Phase II study of LEVI-04 intravenous infusion for the treatment of pain due to osteoarthritis of the knee. 

The trial is evaluating the efficacy, safety, and tolerability of five monthly infusions of LEVI-04 as compared to placebo in participants with radiographic and symptomatic knee osteoarthritis. 

ClinicalTrials.gov ID: NCT05618782.

Phase I Clinical Trial of LEVI-04

Levicept successfully completed a Phase I clinical trial with LEVI-04 in healthy volunteers and patients with osteoarthritis in March 2021. The trial confirmed the favourable safety, tolerability and pharmacokinetic profile of LEVI-04.

ClinicalTrials.gov ID: NCT03227796